Patent US1162009A successfully refreshed from Google Patents.
Patent US4393471A successfully refreshed from Google Patents.
Patent US4983401A successfully refreshed from Google Patents.
US4983401A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Sustained release pharmaceutical preparations having pH controlled membrane coatings
Assignee: KINAFORM TECHNOLOGY Inc A CORP OF OH
•
Filing: 1989-05-22
•
Granted: 1991-01-08
•
Expires: 2009-05-22
Abstract
Abstract A sustained-release pharmaceutical preparation utilizing a pH controlled diffusion membrane composed of a pH sensitive film-forming polymer. The film forming polymer may be an enteric polymer containing phthalic acid with one carboxyl group attached to the enteric polymer via an ester bond, and the second carboxyl group remaining a free acid so that the modified film forming polymer is hydrophobic at low pH and hydrophilic at higher pH. Hydrophobic stearyl side chains are attached to the enteric polymer which causes the pH controlled diffusion membrane to remain insoluble at high pH. Alternatively, the pH sensitive film forming polymer may be a polymer containing hydrophobic and free acid groups so that the modified film forming polymer is hydrophobic at low pH and hydrophilic but insoluble at high pH. In the preferred sustained-release pharmaceutical preparation the film forming polymer is coated into core drug particles to produce a pH controlled diffusion membrane surrounding the core drug and form microparticles which may be admixed with free drug or time-release drug and placed in a gelatin capsule or tabletted.
Inventors
- 👤 Herman J. Eichel
- 👤 Brent D. Massmann
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-02 16:33
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/5005; A61K9/5021; A61K9/5036; A61K9/5042; A61K9/5026
Claims Analysis
Total Claims: 27
Claim 1
Independent Claim
92 words
A sustained-release pharmaceutical preparation comprising multi-units of microparticles comprising: (a) a granular core containing a water soluble drug, (b) a pH controlled diffusion membrane surrounding said core drug, said pH controlled diffusion membrane being formed from a film forming polymer comprising hydrophobic side chains attached to an enteric polymer which results in said film forming polymer being hydrophobic at pH range as found in the stomach and hydrophilic at pH range as found in the intestines, while said pH controlled diffusion membrane remains intact at pH range as found in the intestines.
Claim 2
Dependent Claim
92 words
A sustained-release pharmaceutical preparation comprising multi-units of microparticles comprising: (a) a granular core containing a water soluble drug, (b) a pH controlled diffusion membrane surrounding said core drug, said pH controlled diffusion membrane being formed from a film forming polymer comprising hydrophobic side chains attached to an enteric polymer which results in said film forming polymer being hydrophobic at pH range as found in the stomach and hydrophilic at pH range as found in the intestines, while said pH controlled diffusion membrane remains intact at pH range as found in the intestines.
Claim 3
Dependent Claim
30 words
The sustained-release pharmaceutical preparation of claim 1 wherein said core drug is selected from the group consisting of aspirin, acetaminophen, diphenhydramine hydrochloride, propranolol hydrochloride, dextromethorphan hydrobromide, disopyramide phosphate and furosemide.
Claim 4
Dependent Claim
37 words
The sustained-release pharmacetical preparation of claim 2 wherein said enteric polymer is selected from the group consisting of cellulose acetate phthalate, cellulose acetate trimellitate, hydroxypropylmethyl cellulose phthalate, polyvinyl acetate phthalate, hydroxyethylethyl cellulose phthalate and cellulose acetate tetrahydrophthalate.
Claim 5
Dependent Claim
15 words
The sustained-release pharmaceutical preparation of claim 3 wherein said enteric polymer is cellulose acetate phthalate.
Claim 6
Dependent Claim
30 words
The sustained-release pharmaceutical preparation of claim 4 wherein said hydrophobic side chain is a stearyl side chain formed by esterifying hydroxyl groups on the cellulose acetate phthalate with stearoyl chloride.
Claim 7
Dependent Claim
14 words
The sustained-release pharmaceutical preparation of claim 1 further including free drug or time-release drug.
Claim 8
Dependent Claim
19 words
The sustained-release pharmaceutical preparation of claim 6 wherein said free drug or time-release drug is admixed with said microparticles.
Claim 9
Dependent Claim
20 words
The sustained-release pharmaceutical preparation of claim 6 wherein said free drug or time-release drug is concentrically coated on said microparticles.
Claim 10
Dependent Claim
18 words
The sustained-release pharmaceutical preparation of claim 1 wherein said microparticles are around 110 to 2200 microns in diameter.
Claim 11
Dependent Claim
36 words
The sustained-release pharmaceutical preparation of claim 7 wherein said core drug is in the form of particles about 100 to 2000 microns in diameter, said pH controlled diffusion membrane is about 5 to 100 microns thick.
Claim 12
Dependent Claim
37 words
The sustained-release pharmaceutical preparation of claim 1 wherein said pH controlled diffusion membrane releases 0-15% of said core drug at pH 1.1 in 2 hours and 80-100% of said core drug at pH 6.0-7.5 in 6-24 hours.
Claim 13
Dependent Claim
102 words
A sustained-release pharmaceutical preparation comprising multi-units of microparticles comprising: (a) a granular core containing a water soluble drug, (b) a pH controlled diffusion membrane surrounding said core drug, said pH controlled diffusion membrane being formed from a film forming polymer comprising a first set of subunits which are hydrophobic to keep said pH controlled diffusion membrane intact at pH range as found in the intestines and a second set of subunits which contain free acid groups so that said film forming polymer is hydrophobic at pH range as found in the stomach and hydrophilic at pH range as found in the intestines.
Claim 14
Dependent Claim
102 words
A sustained-release pharmaceutical preparation comprising multi-units of microparticles comprising: (a) a granular core containing a water soluble drug, (b) a pH controlled diffusion membrane surrounding said core drug, said pH controlled diffusion membrane being formed from a film forming polymer comprising a first set of subunits which are hydrophobic to keep said pH controlled diffusion membrane intact at pH range as found in the intestines and a second set of subunits which contain free acid groups so that said film forming polymer is hydrophobic at pH range as found in the stomach and hydrophilic at pH range as found in the intestines.
Claim 15
Dependent Claim
30 words
The sustained-release pharmaceutical preparation of claim 12 wherein said core drug is selected from the group consisting of aspirin, acetaminophen, diphenhydramine hydrochloride, propranolol hydrochloride, dextromethorphan hydrobromide, disopyramide phosphate and furosemide.
Claim 16
Dependent Claim
14 words
The sustained-release pharmaceutical preparation of claim 12 further including free drug or time-release drug.
Claim 17
Dependent Claim
29 words
The sustained-release pharmaceutical preparation of claim 12 wherein said film forming polymer is selected from the group consisting of methacrylic/acrylic acid/ester copolymers, polyethylene maleic anhydride, and polystyrene maleic anhydride.
Claim 18
Dependent Claim
18 words
The sustained-release pharmaceutical preparation of claim 12 wherein said film forming polymer is a methacrylic/acrylic acid ester copolymer.
Claim 19
Dependent Claim
19 words
The sustained-release pharmaceutical preparation of claim 14 wherein said free drug or time-release drug is admixed with said microparticles.
Claim 20
Dependent Claim
20 words
The sustained-release pharmaceutical preparation of claim 13 wherein said free drug or time-release drug is concentrically coated on said microparticles.
Claim 21
Dependent Claim
18 words
The sustained-release pharmaceutical preparation of claim 12 wherein said microparticles are around 110 to 2200 microns in diameter.
Claim 22
Dependent Claim
36 words
The sustained-release pharmaceutical preparation of claim 19 wherein said core drug is in the form of particles about 100 to 2000 microns in diameter, said pH controlled diffusion membrane is about 5 to 100 microns thick.
Claim 23
Dependent Claim
37 words
The sustained-release pharmaceutical preparation of claim 12 wherein said pH controlled diffusion membrane release 0-15% of said core drug at pH 1.1 in 2 hours and 80-100% of said core drug at pH 6.0-7.5 in 6-24 hours.
Claim 24
Dependent Claim
119 words
A sustained-release pharmaceutical preparation comprising multi-units of microparticles comprising: (a) a granular core containing a water soluble drug, said water soluble drug selected from the group consisting of aspirin, acetaminophen, diphenhydramine hydrochloride, propranolol hydrochloride, dextromethorphan hydrobromide, disopyramide phosphate and furosemide, (b) a pH controlled diffusion membrane surrounding said core drug, said pH controlled diffusion membrane being formed from a film forming polymer comprising hydrophobic stearyl side chains attached to an enteric polymer which results in said film forming polymer being hydrophobic at pH range as found in the stomach and hydrophilic at neutral and alkaline pH as found in the intestines, while said pH controlled diffusion membrane remains intact at neutral and alkaline pH as found in the intestines.
Claim 25
Dependent Claim
119 words
A sustained-release pharmaceutical preparation comprising multi-units of microparticles comprising: (a) a granular core containing a water soluble drug, said water soluble drug selected from the group consisting of aspirin, acetaminophen, diphenhydramine hydrochloride, propranolol hydrochloride, dextromethorphan hydrobromide, disopyramide phosphate and furosemide, (b) a pH controlled diffusion membrane surrounding said core drug, said pH controlled diffusion membrane being formed from a film forming polymer comprising hydrophobic stearyl side chains attached to an enteric polymer which results in said film forming polymer being hydrophobic at pH range as found in the stomach and hydrophilic at neutral and alkaline pH as found in the intestines, while said pH controlled diffusion membrane remains intact at neutral and alkaline pH as found in the intestines.
Claim 26
Dependent Claim
63 words
A sustained-release pharmaceutical preparation comprising multi-units of microparticles comprising: (a) a granular core containing a water soluble drug, said water soluble drug selected from the group consisting of aspirin, acetaminophen, diphenhydramine hydrochloride, propranolol hydrochloride, dextromethorphan hydrobromide, disopyramide phosphate and furosemide, (b) a pH controlled diffusion membrane surrounding said core drug, said pH controlled diffusion membrane being formed from a methacrylic/acrylic acid ester copolymer.
Claim 27
Dependent Claim
63 words
A sustained-release pharmaceutical preparation comprising multi-units of microparticles comprising: (a) a granular core containing a water soluble drug, said water soluble drug selected from the group consisting of aspirin, acetaminophen, diphenhydramine hydrochloride, propranolol hydrochloride, dextromethorphan hydrobromide, disopyramide phosphate and furosemide, (b) a pH controlled diffusion membrane surrounding said core drug, said pH controlled diffusion membrane being formed from a methacrylic/acrylic acid ester copolymer.
References Cited (Backward Citations)
US3155590A
Cited
US3341416A
Cited
US3531418A
Cited
US3488418A
Cited
US3492397A
Cited
US4025613A
Cited
US3878276A
Cited
US4083949A
Cited
JPS53108269A
Cited
US4305823A
Cited
US4205060A
Cited
JPS5611687A
Cited
US4377481A
Cited
EP0077956A1
Cited
US4663050A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-01-07 | 1994-07-09 | 1995-01-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-01-07 | 1998-07-09 | 1999-01-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-01-07 | 2002-07-09 | 2003-01-08 | $7700.00 | Window Closed / Lapsed |